Search
Search Results
##search.searchResults.foundPlural##
-
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1620PDF: 808HTML: 223 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2921PDF: 872HTML: 6538Untitled: 250Untitled: 203Untitled: 224Untitled: 231 -
Osteolytic bone lesions – A rare presentation of AML M6.
2023PDF: 1125HTML: 7958Untitled: 208 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9209PDF: 6137HTML: 87988Fig.1b: 197Fig.1c: 204Fig.2a: 190Fig.2b: 190Fig.4: 206Fig.2c: 194Fig.3: 195Tab.1: 246Tab.2: 220Tab.3: 205Tab.4: 240Fig1a: 200 -
OUTBREAK OF BURKHOLDERIA CEPACIA INFECTION: A SYSTEMATIC STUDY IN A HEMATOLOGY-ONCOLOGY UNIT OF A TERTIARY CARE HOSPITAL FROM EASTERN INDIA.
2287PDF: 954HTML: 429Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 231UntitOutbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern Indialed: 358Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 259Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 189Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 200Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 272 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1814PDF: 588HTML: 304 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
3249PDF: 986HTML: 3140flowcytometric result of peripheral blood sample: 187 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4372PDF: 1401HTML: 2064 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1325PDF: 513HTML: 208 -
-
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2573PDF: 960HTML: 324 -
Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission
1716PDF: 799HTML: 267 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3569PDF: 908HTML: 1670figure 1: 174Untitled: 201 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2324PDF: 1046HTML: 5081Cover Letter: 175Figure 2: 173Figure 1: 182Figure 3: 208Figure 4: 179Figure Legend: 193Table 1: 200Table 2: 192Table 3: 191 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4499PDF: 1538HTML: 1565Untitled: 243 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1927PDF: 793HTML: 547 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2365PDF: 1673HTML: 305 -
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
953PDF: 711HTML: 120 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1149PDF: 554HTML: 1702Figures: 179Fifures Sanz: 187tables Sanz: 188Untitled: 185 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2084PDF: 784HTML: 3119 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1304PDF: 781HTML: 327 -
DISTRIBUTION OF DIFFERENT PML/RAR? BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION
1522PDF: 929HTML: 2219Response to reviewers comments: 195 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2847PDF: 1850HTML: 3691Pellagatti Fig 1: 227Pellagatti Fig. 2: 219 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
523PDF: 260HTML: 104 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1496PDF: 922Suppl. Files: 462HTML: 248







